<bill session="111" type="s" number="1634" updated="2023-01-11T13:18:09Z">
  <state datetime="2009-08-06">REFERRED</state>
  <status>
    <introduced datetime="2009-08-06"/>
  </status>
  <introduced datetime="2009-08-06"/>
  <titles>
    <title type="display">Medicare Prescription Drug Coverage Improvement Act</title>
    <title type="official" as="introduced">A bill to amend titles XVIII and XIX of the Social Security Act to protect and improve the benefits provided to dual eligible individuals under the Medicare and Medicaid programs.</title>
    <title type="short" as="introduced">Medicare Prescription Drug Coverage Improvement Act</title>
  </titles>
  <sponsor bioguide_id="R000361"/>
  <cosponsors>
    <cosponsor bioguide_id="A000069" joined="2009-08-06"/>
    <cosponsor bioguide_id="B001265" joined="2009-08-07"/>
    <cosponsor bioguide_id="B000944" joined="2009-08-06"/>
    <cosponsor bioguide_id="W000802" joined="2009-09-08"/>
  </cosponsors>
  <actions>
    <action datetime="2009-08-06">
      <text>Introduced in Senate</text>
    </action>
    <action datetime="2009-08-06">
      <text>Sponsor introductory remarks on measure.</text>
      <reference ref="CR S9029-9030"/>
    </action>
    <action datetime="2009-08-06" state="REFERRED">
      <text>Read twice and referred to the Committee on Finance.</text>
      <reference ref="CR S9030-9038" label="text of measure as introduced"/>
    </action>
  </actions>
  <committees>
    <committee code="SSFI" name="Senate Finance" subcommittee="" activity="Referral"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Health"/>
    <term name="Administrative remedies"/>
    <term name="Department of Health and Human Services"/>
    <term name="Executive agency funding and structure"/>
    <term name="Health information and medical records"/>
    <term name="Licensing and registrations"/>
    <term name="Medicaid"/>
    <term name="Medicare"/>
    <term name="Prescription drugs"/>
    <term name="Public contracts and procurement"/>
  </subjects>
  <amendments/>
  <summary date="2009-11-12T15:47:10Z" status="Introduced in Senate">Medicare Prescription Drug Coverage Improvement Act - Directs the Secretary of Health and Human Services (HHS) to establish a Federal Coordinated Health Care Office within the Centers for Medicare &amp; Medicaid Services to bring together Medicare and Medicaid officials in order to: (1) integrate benefits more effectively under title XVIII (Medicare) of the Social Security Act (SSA) and SSA title XIX (Medicaid); and (2) improve coordination between the federal government and states for individuals dually eligible for benefits under both programs





Amends Part D (Voluntary Prescription Drug Benefit Program) of SSA title XVIII to direct the HHS Secretary to: (1) offer one or more Medicare operated prescription drug plans with a service area consisting of the entire United States; and (2) enter into negotiations with pharmaceutical manufacturers to reduce the purchase cost of covered part D drugs for eligible part D individuals who enroll in such a plan. Provides a premium subsidy and cost-sharing for subsidy eligible individuals. Directs the Secretary to establish a formulary that meets certain requirements.

Outlines accreditation requirements for all specialized Medicare Advantage plans. Revises requirements relating to specialized Medicare Advantage plans for special needs individuals.

Requires continuous updating of eligibility and enrollment data for dual eligible individuals, continuity of prescription drug coverage for such individuals, and collection and sharing of drug utilization data and formulary information for them.

Requires each contractor under the HHS Point of Sale Facilitated Enrollment process to enroll full-benefit dual eligible individuals into a Medicare operated prescription drug plan.





Requires the Secretary to lower covered part D drug prices on behalf of Medicare beneficiaries by: (1) negotiating directly with pharmaceutical manufacturers for additional discounts, rebates, and other price concessions; (2) entering into rebate agreements with manufacturers; (3) educating physicians and pharmacists on the comparative clinical effectiveness of covered part D drugs; and (4) instituting prescription drug prices negotiated under the Federal Supply Schedule of the General Services Administration (GSA) for the reimbursement of covered part D drugs.



Revises requirements for the financial assistance available to low-income Medicare beneficiaries, including those related to enrollment, a Medicare plan complaint system, and use of a single, uniform exceptions and appeals process.</summary>
</bill>
